TMTC3 contributes to the O-mannosylation of E-cadherin, and dysregulation of glycosylation is one of the important mechanisms leading to tumor heterogeneity; in addition, TMTC3 is involved in the regulation of ERS, and ERS affected the malignant growth and progression of tumors. This evidence concerns the gene CDH1 and neoplasm.